These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10693642)

  • 1. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
    Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
    Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anti-human leukocyte antigen allo-immunization in pediatric cadaveric kidney transplantation.
    Emonds MP; Herman J; Dendievel J; Waer M; Van Damme-Lombaerts R
    Pediatr Transplant; 2000 Feb; 4(1):6-11. PubMed ID: 10731052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies.
    Sumitran-Karuppan S
    Transplantation; 1999 Aug; 68(4):502-9. PubMed ID: 10480407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
    O'Rourke RW; Osorio RW; Freise CE; Lou CD; Garovoy MR; Bacchetti P; Ascher NL; Melzer JS; Roberts JP; Stock PG
    Clin Transplant; 2000 Apr; 14(2):167-73. PubMed ID: 10770424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
    Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
    Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
    Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
    Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection.
    Supon P; Constantino D; Hao P; Cagle L; Hahn A; Conti DJ; Freed BM
    Transplantation; 2001 Feb; 71(4):577-80. PubMed ID: 11258441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of AHG-PRA and ELISA-PRA in kidney transplant patients with acute rejection episodes.
    Kaufman A; de Souza Pontes LF; Queiroz Marques MT; Sampaio JC; de Moraes Sobrino Porto LC; de Moraes Souza ER
    Transpl Immunol; 2003; 11(2):175-8. PubMed ID: 12799201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.